Loading ...

Stock Quote acor

acor Stock Price Today

acor Price History

acor Stock Price History

acor History

Last Price acor

Close Price acor

Day Change acor

After Hours Quote acor

Open Price acor

Day Range acor

Year Range acor

Projected Yield acor

Market Cap acor

Stock Volume acor

Average Volume acor

Forward Price acor

PE for acor

PB for acor

PS for acor

PCF for acor

price earnings ratio acor

price to book ratio acor

price to sales ratio acor

price to cash flow ratio acor

Stock Quote Acorda Therapeutics Inc

Acorda Therapeutics Inc Stock Price today

Acorda Therapeutics Inc Price history

Acorda Therapeutics Inc Stock Price history

Acorda Therapeutics Inc history

Last Price Acorda Therapeutics Inc

Close Price Acorda Therapeutics Inc

Day Change Acorda Therapeutics Inc

After Hours Quote for Acorda Therapeutics Inc

Open Price Acorda Therapeutics Inc

Day Range Acorda Therapeutics Inc

Year Range Acorda Therapeutics Inc

Projected Yield Acorda Therapeutics Inc

Market Cap Acorda Therapeutics Inc

Stock Volume Acorda Therapeutics Inc

Average Volume Acorda Therapeutics Inc

Forward Price Acorda Therapeutics Inc

pe Acorda Therapeutics Inc

pb Acorda Therapeutics Inc

ps Acorda Therapeutics Inc

pcf Acorda Therapeutics Inc

price earnings ratio Acorda Therapeutics Inc

price to book ratio Acorda Therapeutics Inc

price to sales ratio Acorda Therapeutics Inc

price to cash flow ratio Acorda Therapeutics Inc

What Does This Company Do?
Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Speculative Growth
Employees
421
Stock Style
Small Growth

Key Stats  ACOR More...

Key Stats ACOR

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  acor - Acorda Therapeutics Inc More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  acor - Acorda Therapeutics Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports acor - Acorda Therapeutics IncMore...

Click above to view more mutual fund data and stats for acor - Acorda Therapeutics Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   ACOR More ...

Ownership ACOR

Fidelity® Select Biotechnology Portfolio
Eagle Small Cap Growth A
ClearBridge Small Cap Growth A
Vanguard Small Cap Index
Vanguard Total Stock Mkt Idx
Stock Price Quote: acor Acorda Therapeutics Inc - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: acmuy - Acom Co Ltd ADR  |  Next: acor - Acorda Therapeutics Inc